{
    "eid": "2-s2.0-85129073305",
    "title": "A simple LC-MS/MS method for pharmacokinetic study of carvedilol and 4 / -hydroxyphenyl carvedilol at a low dose",
    "cover-date": "2022-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology, Toxicology and Pharmaceutics (all)",
            "@code": "3000",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [],
    "authors": [
        "Wanna Eiamart",
        "Nantaporn Prompila",
        "Yaowatree Jumroen",
        "Nonlanee Sayankuldilok",
        "Pajaree Chariyavilaskul",
        "Supeecha Wittayalertpanya"
    ],
    "citedby-count": 1,
    "ref-count": 26,
    "ref-list": [
        "Carvedilol: A review of its pharmacodynamics and pharmacokinetic properties, and therapeutic efficacy",
        "Carvedilol: A review of its use in chronic heart failure",
        "Pharmacokinetics of carvedilol in older and younger patients",
        "Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker",
        "Preparation and characterization of solid dispersions of carvedilol with PVP K30",
        "Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study",
        "Liquid chromatographic assay and disposition of carvedilol in health volunteers",
        "Pharmacokinetics and disposition of carvedilol in humans",
        "Metabolism of carvedilol in man",
        "In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R(+)-and S(-)-carvedilol",
        "Preclinical and clinical pharmacology of carvedilol",
        "The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency",
        "Pharmacokinetic and blood pressure effects of carvedilol in patients with chronic renal failure",
        "UPLC-MS/MS assay for the simultaneous quantification of carvedilol and its active metabolite 4'-hydroxyphenyl carvedilol in human plasma to support a bioequivalence study in healthy volunteers",
        "Quantification of carvedilol in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: Applicationto bioequivalence study",
        "Rapid and sensitive carvedilol assay in human plasma using a high-performance liquid chromatography with mass/mass spectrometer detection employed for a bioequivalence study",
        "Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: Application to a clinical pharmacokinetic study",
        "Low-volume LC-MS/MS method for the pharmacokinetic investigation of carvedilol, enalapril and their metabolites in whole blood and plasma: Application to a paediatric clinical trial",
        "Simultaneous quantification of vortioxetine, carvedilol and its active metabolite 4-hydroxyphenyl carvedilol in rat plasma by UPLC-MS/MS: Application to their pharmacokinetic interaction study",
        "A validated enantioselective LCMS/ MS assay for the simultaneous determination of carvedilol and its pharmacologically active 4'-hydroxyphenyl metabolite in human plasma: Application to a clinical pharmacokinetic study",
        "Bioequivalence of Cadilan tablet 12. 5 mg to Dilatrend\u00ae tablet 12. 5 mg (Carvedilol 12. 5 mg)",
        "Bioequivalence of Carvelol tablet to Dilatrend tablet (Carvedilol 25 mg)",
        "Influence of CYP2D6 polymorphism on the pharmacokinetic/pharmacodynamics characteristics of carvedilol in healthy Korean volunteers",
        "Effect of CYP2D610 on the Pharmacokinetics of R-and S-Carvedilol in Healthy Japanese Volunteers"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "funding": []
}